Why wasn't the APPROVe trial stopped earlier?

The APPROVe trial began enrollment in 2000 and was being monitored by an independent data safety monitoring board (DSMB). It was not stopped earlier because the results for the first 18 months of the trial did not show that Vioxx carried any increased risk of cardiovascular events.

The information on this page is meant to provide a general overview of the law. The laws in your state and/or city may deviate significantly from those described here. If you have specific questions related to your situation you should speak with a local attorney.

Additional Vioxx Articles

Search LawInfo's Vioxx Resources